Clinical Psychology
and Psychotherapy

Clinical Psychology and Psychotherapy

Dysthymic Disorder (Dysthymia)


Dysthymic Disorder (also called dysthymia) refers to a disorder in which the patients have for many years suffered under a slightly depressed mood. In addition to the depressive mood the patients suffer from symptoms such as decreased appetite or increased appetite, insomnia or excessive sleepiness, loss of energy or fatigue, low self-esteem, poor concentration, poor decision-making ability and a sense of hopelessness.

Definition according to ICD-10

The International Classification of Diseases (ICD-10) defines dysthymia (F34.1) as a disorder in which individuals have suffered for several years in the majority of days of a depressive mood, and which, regarding the severity and duration of the symptoms, is not meeting the criteria for major depressive disorder (ICD-10 F33).

Definition based on the DSM-IV

The Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) defines the dysthymic disorder (DSM-IV 300.4) as a disorder in which individuals have for a period of at least two years (in children / adolescents at least one year) for most of the day more than half of all days suffered of a depressive mood.

In addition to the depressive mood the patients suffer in the same period of at least two of the following symptoms:

  • Decreased appetite or increased appetite;
  • Insomnia or excessive sleepiness;
  • Loss of energy or fatigue;
  • Low self-esteem;
  • Poor concentration and decision making;
  • Feeling of hopelessness.

During the 2-year-period, no consistent interval for two months or longer without the depressive symptoms must occur.

During the first two years of dysthymic disorder (in children / adolescents one year) at no time an episode of a major depression must have occurred. In the later course of dysthymic disorder "superimposed episodes" of major depressive disorder may occur, in this case the diagnosis is "dysthymic disorder with superimposed episodes of major depression".

Previous to the dysthymic disorder no manic, mixed or hypomanic episode must have occurred, and the criteria for cyclothymic disorder must not have been met. The symptoms must not occur exclusively in the course of a chronic psychotic disorder. The symptoms must not occur due to the direct physical effects of a substance (such as drugs) or because of a physical illness.

The symptoms must not cause a clinically significant distress or impairment in social, occupational or other important areas of functioning.

Double Depression

Double depression refers to a dysthymia, which is superimposed by an episode of major depressive disorder. The double depression corresponds to the DSM-IV diagnosis of "dysthymic disorder with superimposed episodes of major depression."

Neurotic Depression

The term neurotic depression (also called depressive neurosis) was and is particularly evident in psychoanalytic parlance, used to distinguish depressive illnesses which developed primarily reactive of the so-called psychotic depression (also called endogenous depression or melancholy).

The neurotic depression is characterized by a persistent depressed mood, while the psychotic depression is characterized mostly by recurrent episodes, probably with intermittent manic episodes.

While the diagnosis of "neurotic depression" was still present in the ICD-9, in the ICD-10 it was replaced by the diagnosis "dysthymia" and "recurrent depressive disorder". This led to considerable criticism because, according to some opinions, the latter diagnoses do not adequately capture the concept of neurotic depression.


The dysthymia occurs with a point prevalence of approximately 3% and a lifetime risk of about 6%. The onset is often in adolescence. In contrast to the major depressive disorder there is no gender difference in the frequency of occurrence.



The treatment of dysthymia has not been studied as extensively as for example the treatment of major depressive disorder. Overall, the treatment of dysthymia is in many areas similar to the treatment of major depression.

Scientific studies have proved in particular the effectiveness of the so-called cognitive behavioral therapy, the interpersonal therapy, the so-called Cognitive Behavioral Analysis System of Psychotherapy (CBASP) as well as of drug treatment, such as the use of amisulpride or sertraline. The best long-term therapeutic success seems likely with a combination treatment of psychotherapy and medication (cf. Ravindran 1999, Browne 2002).

© Sandra Elze, M.D. & Michael Elze, M.D.
Prien am Chiemsee / Rosenheim,



Dysthymic Disorder: Treatment

Amore M, Jori MC (2001). Faster response on amisulpride 50 mg versus sertraline 50-100 mg in patients with dysthymia or double depression: a randomized, double-blind, parallel group study. International clinical psychopharmacology 16 (6): 317-24.

Browne G, Steiner M, Roberts J, Gafni A, Byrne C, Dunn E, Bell B, Mills M, Chalklin L, Wallik D, Kraemer J (2002). Sertraline and/or interpersonal psychotherapy for patients with dysthymic disorder in primary care: 6-month comparison with longitudinal 2-year follow-up of effectiveness and costs. Journal of affective disorders 68 (2-3): 317-30.
Abstract >>

Ravindran AV, Anisman H, Merali Z, Charbonneau Y, Telner J, Bialik RJ, Wiens A, Ellis J, Griffiths J (1999). Treatment of primary dysthymia with group cognitive therapy and pharmacotherapy: clinical symptoms and functional impairments. The American journal of psychiatry 156 (10): 1608-17.
Abstract >>

Ravindran AV, Guelfi JD, Lane RM, Cassano GB (2000). Treatment of dysthymia with sertraline: a double-blind, placebo-controlled trial in dysthymic patients without major depression. The Journal of clinical psychiatry  61 (11): 821-7.

Thase ME, Fava M, Halbreich U, Kocsis JH, Koran L, Davidson J, Rosenbaum J, Harrison W (1996). A placebo-controlled, randomized clinical trial comparing sertraline and imipramine for the treatment of dysthymia. Archives of general psychiatry 53 (9): 777-84.


Kocsis JH, Gelenberg AJ, Rothbaum BO, Klein DN, Trivedi MH, Manber R, Keller MB, Leon AC, Wisniewski SR, Arnow BA, Markowitz JC, Thase ME; REVAMP Investigators (2009). Cognitive behavioral analysis system of psychotherapy and brief supportive psychotherapy for augmentation of antidepressant nonresponse in chronic depression: the REVAMP Trial. Arch Gen Psychiatry; 66(11): 1178-88.
Abstract >>

McCullough JP (2000). Treatment for Chronic Depression: Cognitive Behavioral Analysis System of Psychotherapy (CBASP). New York: Guilford. Deutsche Übersetzung: McCullough JP (Hrsg.) (2006). Behandlung der chronischen Depression: Cognitive Behavioral Analysis System of Psychotherapy - CBASP. München: Elsevier

Schramm E, Caspar F, Berger M (2006). Spezifische Therapie für Depression - Das “Cognitive Behavioral Analysis System of Psychotherapy“ nach McCullough. Nervenarzt; 77(3): 355-371.
Abstract >>

Dysthyme Störung  Dysthymic Disorder  Dysthymic Disorder

© Sandra Elze, M.D. & Michael Elze, M.D.
Prien am Chiemsee / Rosenheim,


Average Rating:

5 Stars   5  Stars   ( 7  readers rated this article.)

Please rate this article:



Share This Page:

Do you have further questions or are there other topics you are interested in?
Enter your keywords here to search on our websites:


Mental Wellness & Health

Mood Disorders
Depression  -  Bipolar Disorder  -  Mania  -  Hypomania  -  Dysthymic Disorder

Posttraumatic Stress Disorder

Clinical Psychology and Psychotherapy

Anxiety Disorders
Social Phobia  -  Generalized Anxiety Disorder

Obsessive-Compulsive Disorder
Internet Use Disorder

Mood Disorders
Depressive Disorders  -  Bipolar Affective Disorder

Posttraumatic Stress Disorder

Legal Notice and Terms of Use - Pivacy Policy
Please note our information on medical and health topics.

Back To Top  -  Print Print This Page

© Sandra Elze, M.D. & Michael Elze, M.D.
Prien am Chiemsee / Rosenheim,
Last updated: 03-24-2016

Deutsch  English  English  Español